The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...

Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company developing innovative antibody-based therapeutics, today announced that the first patient has been dosed in a Phase 1a/1b ...

Credelio Quattro combines four active ingredients to protect dogs against six parasite types, including tapeworms and ...

Your body might be sending you hints about your health.

The Trump administration is running out of excuses to explain away the president’s relationship with deceased child sex ...

Explore how boron compounds are revolutionising drug development with new stable boron-fluorine compounds for better ...

STOCKHOLM, SE / ACCESS Newswire / February 3, 2026 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with NSCLC, RCC, colorectal cancer ...

Learn which nanocarriers matter now (LNPs, exosomes, polymers) and the key hurdles in biodistribution, safety, CMC, and ...

Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in ...

STOCKHOLM, SE / ACCESS Newswire / February 3, 2026 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the n ...

In an industry often clouded by opaque sourcing and inconsistent quality, Peptide Hubs stands as a beacon of transparency. Every product in the new lineup undergoes a rigorous journey before it ...